Cytotoxicity and ROS production of manufactured silver nanoparticles of different sizes in hepatoma and leukemia cells

Journal of Applied Toxicology

Volumn 34, Issue 4, 2014, Pages 413-423

  Avalos, Alicia ^a   Haza, Ana Isabel ^a   Mateo, Diego ^a   Morales, Paloma ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Cytotoxicity; Glutathione; N acetyl cisteine; Reactive oxygen species; Silver nanoparticles; Superoxide dismutase

Indexed keywords

GLUTATHIONE; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SUPEROXIDE DISMUTASE;

ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INHIBITION KINETICS; LEUKEMIA CELL; OXIDATIVE STRESS; PARTICLE SIZE; PRIORITY JOURNAL; TOXICITY;

CYTOTOXICITY; GLUTATHIONE; N-ACETYL-CISTEINE; REACTIVE OXYGEN SPECIES; SILVER NANOPARTICLES; SUPEROXIDE DISMUTASE;

ACETYLCYSTEINE; CELL CULTURE TECHNIQUES; CELL SURVIVAL; FREE RADICAL SCAVENGERS; GLUTATHIONE; HEP G2 CELLS; HL-60 CELLS; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; REACTIVE OXYGEN SPECIES; SILVER; SUPEROXIDE DISMUTASE; SURFACE PROPERTIES;

EID: 84893712676     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.2957     Document Type: Article

References (59)

1. Ahamed M, Siddiqui MKJ. 2007. Low level lead exposure and oxidative stress: Current opinions. Clin. Chim. Acta 383: 57-64.
2. Albanese A, Sykes EA, Chan WC. 2010. Rough around the Edges: The inflammatory response of microglial cells to spiky nanoparticles. ACS Nano 4: 2490-2493.
3. Anderson MF, Nilsson M, Eriksson PS, Sims NR. 2004. Glutathione monoethyl ester provides neuroprotection in a rat model of stroke. Neurosci. Lett. 354: 163-165.
4. Arora S, Jain J, Rajwade JM, Paknikar KM. 2008. Cellular responses induced by silver nanoparticles: In vitro studies. Toxicol. Lett. 179: 93-100.
5. Arora S, Jain J, Rajwade JM, Paknikar KM. 2009. Interactions of silver nanoparticles with primary mouse fibroblasts and liver cells. Toxicol. Appl. Pharmacol. 236: 310-318.
6. Barnard AS, Xu HF. 2008. An environmentally sensitive phase map of titania nanocrystals. ACS Nano 2: 2237-2242.
7. Barillet S, Jugan ML, Laye M, Leconte Y, Herlin-Boime N, Reynaud C, Carrère M. 2010. In vitro evaluation of SiC nanoparticles impact on A549 pulmonary cells: cytogenotoxicity and oxidative stress. Toxicol. Lett. 198: 324-330.
8. Boucher W, Stern JM, Kotsinyan V, Kempuraj D, Papaliodis D, Cohen MS, Theoharides TC. 2008. Intravesical nanocrystalline silver decreases experimental bladder inflammation. J. Urol. 179: 1598-1602.
9. Carlson C, Hussain SM, Schrand AM, Braydich-Stolle LK, Hess KL, Jones RL, Schlager JJ. 2008. Unique cellular interaction of silver nanoparticles: size dependent generation of reactive oxygen species. J. Phys. Chem. B 112: 13608-13619.
10. Cha K, Hong HW, Choi YG, Lee MJ, Park JH, Chae HK, Ryu G, Myung H. 2008. Comparison of acute responses of mice livers to short-term exposure to nano-sized or micro-sized silver particles. Biotechnol. Lett. 30: 1893-1899.
11. Chen X, Schluesener HJ. 2008. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 176: 1-12.
12. Chithrani BD, Ghazani AA, Chan WCW. 2006. Determining the size and shape dependence of gold nanoparticle uptake by mammalian cells. Nano Lett. 6: 662-668.
13. Clift MJD, Rothen-Rutishauser B, Brown DM, Duffin R, Donaldson K, Proudfoot L, Guy K, Stone V. 2008. The impact of different nanoparticle surface chemistry and size on uptake and toxicity in a murine macrophage cell line. Toxicol. Appl. Pharmacol. 232: 418-427.
14. th 2011 on the definition of nanomaterial (2011/696/EU). Off. J. Eur. Union 2011 275: 38-40.
15. Colvin VL. 2003. The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21: 1166-1170.
16. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips AJAM, Geertsma RE. 2008. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29: 1912-1919.
17. Dewarijee S, Maiti A, Sahu R, Dua TK, Mandal V. 2009. Effective control of type 2 diabetes through antioxidant defense by edible fruits of Diospyros peregrina. Evid. Based Complement. Alternat. Med. 2011: 1-7.
18. Donaldson K, Stone V, Tran CL, Kreyling W, Borm PJA. 2004. Nanotoxicology. Occup. Environ. Med. 61: 727-728.
19. Elsaesser A, Howard CV. 2012. Toxicology of nanoparticles. Adv. Drug Deliv. Rev. 69: 129-137.
20. Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. 2009. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol. Lett. 190: 156-162.
21. García A, Morales P, Arranz N, Delgado E, Rafter J, Haza AI. 2008. Induction of apoptosis and reactive oxygen species production by N-nitrosopiperidine and N-nitrosodibutylamine in human leukemia cells. J. Appl. Toxicol. 28: 455-465.
22. Henig RM. 2007. Our silver-coated future. Onearth Fall.: 23-29.
23. Hsin YH, Chen CF, Huang S, Shih TS, Lai PS, Chueh PJ. 2008. The apoptotic effect of nanosilver is mediated by ROS- and JNK dependent mechanism involving the mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 179: 130-139.
24. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. 2005. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol. In Vitro 19: 975-983.
25. Hussain S, Boland S, Baeza-Squiban A, Hamel R, Thomassen LC, Martens JA, Billon-Galland MA, Fleury-Feith J, Moisan F, Pairon JC, Marano F. 2009. Oxidative stress and proinflammatory effects of carbon black and titanium dioxide nanoparticles: role of particle surface area and internalized amount. Toxicology 260: 142-149.
26. Iversen TG, Skotland T, Sandvig K. 2011. Endocytosis and intracellular transport of nanoparticles: present knowledge and need for future studies. Nano Today 6: 176-185.
27. Jin CY, Zhu BS, Wang XF, Lu QH. 2008. Cytotoxicity of titanium dioxide nanoparticles in mouse fibroblast cells. Chem. Res. Toxicol. 21: 1871-1877.
28. Johnston HJ, Hutchison G, Christensen FM, Peters S, Hankin S, Stone V. 2010. A review of the in vivo and in vitro toxicity of silver and gold particulates: Particle attributes and biological mechanisms responsible for the observed toxicity. Crit. Rev. Toxicol. 40: 328-346.
29. Jos A, Pichardo S, Puerto M, Sánchez E, Gribo A, Camean AM. 2009. Cytotoxicity of carboxylic acid functionalized single wall carbón nanotubes on the human intestinal cell line Caco-2. Toxicol. In Vitro 23: 1491-1496.
30. Kato H. 2011. In vitro assays: Tracking nanoparticles inside cells. Nat. Nanotechnol. 6: 139-140.
31. Kim HR, Kim MJ, Lee SY, Oh SM, Chung KH. 2011. Genotoxic effects of silver nanoparticles stimulated by oxidative stress in human normal bronchial epithelial (BEAS-2B) cells. Mutat. Res. 726: 129-135.
32. Kim S, Choi JE, Choi J, Chung K, Park K, Yi J, Ryu D. 2009. Oxidative stress-dependent toxicity of silver nanoparticles in human hepatoma cells. Toxicol. In Vitro 23: 1076-1084.
33. Liu Z, Davis C, Cai W, He L, Chen X, Dai H. 2008. Circulation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopy. Proc. Natl. Acad. Sci. U. S. A. 105: 1410-1415.
34. Liu S, Wei L, Hao L, Fang N, Chang MW, Xu R, Yang Y, Chen Y. 2009. Sharper and faster "nano darts" kill more bacteria: a study of antibacterial activity of individually dispersed pristine single-walled carbon nanotube. ACS Nano 3: 3891-3902.
35. Lundqvist M, Stigler J, Elia G, Lynch I, Cerdevall T, Dawson K. 2008. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc. Natl. Acad. Sci. U. S. A. 105: 14265-14270.
36. Lynch I, Dawson K. 2008. Protein-nanoparticle interactions. Nanotoday 3: 40-47.
37. Mahmood M, Casciano DA, Mocan T, Iancu C, Xu Y, Mocan L, Iancu DT, Dervishi E, Li Z, Abdalmuhsen M, Biris AR, Ali N, Howard P, Biris AS. 2010. Cytotoxicity and biological effects of functional nanomaterials delivered to various cell lines. J. Appl. Toxicol. 30: 74-83.
38. Maurer-Jones MA, Lin YS, Haynes CL. 2010. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 4: 3363-3373.
39. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Walker NJ, Warheit DB. 2006. Safe handling in nanotechnology. Nature 444: 267-269.
40. Mukherjee SG, O'Claonadh N, Casey A, Chambers G. 2012. Comparative in vitro cytotoxicity study of silver nanoparticle on two mammalian cells lines. Toxicol. In Vitro 26: 238-251.
41. Murdock RC, Braydich-Stolle L, Schrand AM, Schlager JJ, Hussain SM. 2008. Characterization of nanomaterial dispersion in solution prior to in vitro exposure using dynamic light scattering technique. Toxicol. Sci. 101: 239-253.
42. Nel A, Xia T, Mädler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311: 622-627.
43. Oberdörster G, Finkelstein JN, Johnston C, Gelein R, Cox C, Baggs R, Elder ACP. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health Eff. Inst. 96: 5-74.
44. Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 113: 823-839.
45. Piao MJ, Kang KA, Lee IK, Kim HS, Kim S, Choi JY, Choi J, Hyun JW. 2011. Silver nanoparticles induce oxidative cell damage in human liver cells through inhibition of reduced glutathione and induction of mitochondria-involved apoptosis. Toxicol. Lett. 201: 92-100.
46. Porter AE, Gass M, Bendall JS, Muller K, Goode A, Skepper JN, Midgley PA, Welland M. 2009. Uptake of noncytotoxic acid-treated single-walled carbon nanotubes into the cytoplasm of human macrophage cells. ACS Nano 3: 1485-1492.
47. Renwick LC, Brown D, Clouter A, Donaldson K. 2004. Increased inflammation and altered macrophage chemotactic responses caused by two ultrafine particle types. Occup. Environ. Med. 61: 442-446.
48. Savage N, Thomas TA, Duncan JS. 2007. Nanotechnology applications and implications research supported by the US Environmental Protection Agency STAR grants program. J. Environ. Monit. 9: 1046-1054.
49. Sayes MC, Wahi R, Kurian PA, Liu Y, West JL, Ausman KD, Warheit DB, Colvin VL. 2006. Correlating nanoscale titania structure with toxicity: a cytotoxicity and inflammatory response study with human dermal fibroblasts and human lung epithelial cells. Toxicol. Sci. 92: 174-185.
50. Sies H. 1999. Glutathione and its role in cellular functions. Free Radic. Biol. Med. 27: 916-921.
51. Sonavane G, Tomoda K, Sano A, Ohshima H, Terada H, Makino K. 2008. In vitro permeation of gold nanoparticles through rat skin and rat intestine: effect of particle size. Coll. Surf. B. Biointerfaces 65: 1-10.
52. Stickler DJ. 2000. Biomaterials to prevent nosocomial infections: is silver the gold standard?. Curr. Opin. Infect. Dis. 13: 389-393.
53. Tripathy A, Chandrasekran N, Raichur AM, Murkherjee A. 2008. Antibacterial applications of silver nanoparticles synthesized by aqueous extract of Azadirachta indica (Neem) leaves. J. Biomed. Nanotech. 4: 1-6.
54. Varela JA, Bexiga MG, Aberg C, Simpson JC, Dawson K. 2012. Quantifying size-dependent interactions between fluorescently labeled polystyrene nanoparticles and mammalian cells. J. Nanobiotechnology 10: 39-44.
55. Wang SH, Lee CW, Chiou A, Wei PK. 2010. Size-dependent endocytosis of gold nanoparticles studied by three-dimensional mapping of plasmonic scattering images. J. Nanobiotechnology 8: 33-45.
56. Warheit DB. 2008. How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization. Toxicol. Sci. 101: 183-185.
57. Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. 2006. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett. 6: 1794-1807.
58. Xiao Y, Forry SP, Gao X, Holbrook RD, Telford WG, Tona A. 2010. Dynamics and mechanisms of quantum dot nanoparticle cellular uptake. J. Nanobiotechnology 8: 13.
59. Zafarullah M, Li WQ, Sylvester J, Ahmad M. 2003. Molecular mechanisms of N-acetylcysteine actions. Cell. Mol. Life Sci. 60: 6-20.